BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Niu ZS, Wang WH, Niu XJ. Recent progress in molecular mechanisms of postoperative recurrence and metastasis of hepatocellular carcinoma. World J Gastroenterol 2022; 28(46): 6433-6477 [PMID: 36569275 DOI: 10.3748/wjg.v28.i46.6433]
URL: https://www.wjgnet.com/1007-9327/full/v28/i46/6433.htm
Number Citing Articles
1
E.L. Bueverova, O.Yu. Zolnikova, M.A. Paltzev. Immune microenvironment in hepatocellular carcinoma: current concepts and the role of blockade of immune checkpointsMolekulyarnaya Meditsina (Molecular medicine) 2024; 22(1): 3 doi: 10.29296/24999490-2024-01-01
2
Huanjie Zhou, Haiping Zheng, Ying Wang, Ming Lao, Hong Shu, Meifang Huang, Chao Ou. Nomogram for Predicting Postoperative Pulmonary Metastasis in Hepatocellular Carcinoma Based on Inflammatory MarkersCancer Control 2024; 31 doi: 10.1177/10732748241236333
3
Junyu Wu, Yau‐Tuen Chan, Yuanjun Lu, Ning Wang, Yibin Feng. The tumor microenvironment in the postsurgical liver: Mechanisms and potential targets of postoperative recurrence in human hepatocellular carcinomaMedicinal Research Reviews 2023; 43(6): 1946 doi: 10.1002/med.21967
4
Xiaqing Gao, Chunting Yang, Hailong Li, Lihua Shao, Meng Wang, Rong Su. EMT-related gene risk model establishment for prognosis and drug treatment efficiency prediction in hepatocellular carcinomaScientific Reports 2023; 13(1) doi: 10.1038/s41598-023-47886-z
5
Yu-Bo Zhang, Gang Yang, Yang Bu, Peng Lei, Wei Zhang, Dan-Yang Zhang. Development of a machine learning-based model for predicting risk of early postoperative recurrence of hepatocellular carcinomaWorld Journal of Gastroenterology 2023; 29(43): 5804-5817 doi: 10.3748/wjg.v29.i43.5804
6
Stavros P. Papadakos, Daniele Ferraro, Gabriele Carbone, Adam Enver Frampton, Giovanni Vennarecci, Stylianos Kykalos, Dimitrios Schizas, Stamatios Theocharis, Nikolaos Machairas. The Emerging Role of Metformin in the Treatment of Hepatocellular Carcinoma: Is There Any Value in Repurposing Metformin for HCC Immunotherapy?Cancers 2023; 15(12): 3161 doi: 10.3390/cancers15123161